The parallel, randomized, double-masked, activecontrolled trial is generally thought to be the most rigorous and unbiased design to adequately compare two glaucoma medicines. Important to this design is the intraocular pressure entry criteria. The lower limit of intraocular pressure is usually set at least >21 mmHg to help assure the study population has the appropriate diagnosis (ocular hypert...
